Coratus Genetics will use clinical research services from PPD as part of a Phase II b gene therapy trial, Coratus said Tuesday.

The trial is to evaluate the safety and efficacy of a treatment for patients with severe angina. PPD will provide Coratus with medical monitoring, data management, biostatistics services and other information. The trial will include 404 patients at some 25 cardiac medical centers.

Coratus is based in Atlanta. PPD is based in Wilmington, NC.

The trial for Genasis will include 404 patients at some 25 cardiac medical centers.

Coratus: www.corautus.com

PPD: www.ppdi.com